https://prabadinews.com/
  • October 10, 2026
  • Last Update July 17, 2026 9:28 pm
  • United States of America

AdminPrabadin

administrator

DeepSeek’s disruption: what it means for TSMC and the AI supply chain

Artificial Intelligence (AI) is an unstoppable trend. The US will remain strong, not just with OpenAI. Since DeepSeek has broken…

DeepSeek disruption: Could China’s supply chain take the lead?

Just before the Lunar New Year celebrations around the world, a black swan emerged, plunging the global technology industry into…

EMS Watch: Differences in EMS/ODM development across regions according to profit margin

The top 20 EMS/ODM companies in 2024 include 9 from China, 7 from Taiwan, and 4 from North America, ranked…

CHPT co-founder outlines new AI strategies to tackle challenges and seize growth opportunities in Taiwan’s semiconductor market.

The semiconductor industry is swiftly advancing due to high-performance computing and AI smartphones, creating opportunities for AI semiconductors. With the…

Chinese automakers face challenges in auto parts localization amid quality demands

The automotive industry’s stringent safety and reliability requirements are presenting significant challenges to the Chinese government’s ongoing push to increase…

AI robots emerge as new competitive frontier for automakers

The convergence of AI robotics and automotive manufacturing presents a critical turning point for the industry. As automakers explore artificial…

FDA Approves Novel Non-Opioid Treatment for Moderate to Severe Acute Pain

The FDA approved Journavx (suzetrigine) 50 milligram oral tablets, a first-in-class non-opioid analgesic to treat moderate to severe acute pain…

Drug Trials Snapshots: BIMZELX

BIMZELX is an anti-interleukin (IL)-17A and IL-17F monoclonal antibody that is indicated for the treatment of adults with moderate to…

Drug Trials Snapshot: LIVTENCITY

LIVTENCITY is a prescription medicine used to treat cytomegalovirus (CMV) infection and disease.

Drug Trials Snapshots: LEQSELVI

LEQSELVI is a Janus kinase (JAK) inhibitor that is indicated for the treatment of adults with severe alopecia areata (AA).